Heuron
Heuron Co., Ltd. is a medical AI healthtech company specializing in neurovascular and neurodegenerative disease diagnostics. Founded by neurologists, it develops AI-powered software solutions for rapid and accurate diagnosis and treatment decisions in brain diseases such as stroke, Parkinson's, and dementia. Its key products include Heuron StroCare Suite™ for stroke and Heuron AgingCare Suite™ for degenerative brain diseases. The company has achieved multiple regulatory approvals including FDA and Taiwan FDA certifications, and collaborates with global medical institutions. It operates with a business model based on AI software licensing and partnerships, focusing on clinical validation and innovation in brain health AI. Heuron has offices in South Korea, the US, and Singapore, and has secured significant funding rounds and international research collaborations, positioning it as a leader in AI-driven neurodiagnostics.
Heuron
Heuron Co., Ltd. is a medical AI healthtech company specializing in neurovascular and neurodegenerative disease diagnostics. Founded by neurologists, it develops AI-powered software solutions for rapid and accurate diagnosis and treatment decisions in brain diseases such as stroke, Parkinson's, and dementia. Its key products include Heuron StroCare Suite™ for stroke and Heuron AgingCare Suite™ for degenerative brain diseases. The company has achieved multiple regulatory approvals including FDA and Taiwan FDA certifications, and collaborates with global medical institutions. It operates with a business model based on AI software licensing and partnerships, focusing on clinical validation and innovation in brain health AI. Heuron has offices in South Korea, the US, and Singapore, and has secured significant funding rounds and international research collaborations, positioning it as a leader in AI-driven neurodiagnostics.